The Italian company GPQ Srl was founded in 1994 and has since that researched and developed medical devices and cosmetic products for all skin types. Furthermore, the company is qualified in technical and scientific fields.
GPQ Srl is especially known for their WiQo product line of medical devices including their bio-revitalizing peel, PRX-T33. PRX-T33 is a registered trademark owned by GPQ Srl.
Adlyxin (Lixisenatide) Pens
Adlyxin (Lixisenatide) Pens, also known as lixisenatide, is a daily injectable prescription medication. It is used in adults with type 2 diabetes mellitus (T2DM) to better glycemic control in addition to diet and exercise. Controlling hyperglycemia with Adlyxin prevents downstream complications such as kidney damage, limb loss, heart attack, blindness, stroke, or nerve problems. It is important that diabetes remains controlled to lessen the chance of related complications. Adlyxin is provided as a single-patient-use prefilled pen.